A lot has happened in the world of sterile, compounded medicine in the past decade – from the creation of sections 503A and 503B in the Federal Food, Drug, and Cosmetic Act, to the complete overhaul of the USP <797> standards used to manufacture and test products. The role of a compounding pharmacist has expanded. Compounders must navigate how to create products with tighter oversight and shorter shelf-life. To do so, compounding pharmacists must become supply chain, manufacturing, and Quality Control experts. Read More >